D.A. Davidson & Co. Exact Sciences Corp Transaction History

D.A. Davidson & Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$47.19 - $70.77 $160,681 - $240,971	3,405 New	3,405 $230,000
Q2 2022 Jul 28, 2022	SELL	$35.61 - $76.23 $202,870 - $434,282	-5,697 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$72.5 - $100.68 $26,027 - $36,144	-359 Reduced 5.93%	5,697 $443,000
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $37,720 - $51,852	-418 Reduced 6.46%	6,056 $578,000
Q2 2021 Aug 10, 2021	BUY	$93.66 - $139.27 $9,366 - $13,927	100 Added 1.57%	6,474 $805,000
Q1 2021 May 07, 2021	BUY	$116.57 - $155.01 $507,545 - $674,913	4,354 Added 215.54%	6,374 $840,000
Q3 2020 Nov 02, 2020	BUY	$72.92 - $102.01 $147,298 - $206,060	2,020 New	2,020 $206,000
Q3 2017 Nov 08, 2017	SELL	$37.05 - $47.12 $37,050 - $47,120	-1,000 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	1,000	1,000 $0

666

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.